[Biological principles of chemoradiotherapy].

Radio-chemotherapy combinations, especially their concomitant associations, are widely used in the treatment of cancer. The development of these associations has been so far related more to clinical research than to laboratory experiments. The biological basis of the use of these agents relies on their complementarity which concerns the cellular and molecular mechanisms involved in lethality (hypoxia, sensitivity throughout the cycle, DNA repair, apoptosis), spatial and temporal cooperation, etc. Laboratory experiments can determine favorable conditions for additivity, or supra-additivity, but also for infra-additive interactions as well as real antagonism which should be avoided in the clinic. It is however often difficult to transfer this information into the clinic since the conditions which allow additivity or supra-additivity are generally very narrow, and unlikely to be realised in the patient. General clinical conditions are more compatible with infra-additive interactions.